|
EconStor >
Federal Reserve Bank of New York >
Staff Reports, Federal Reserve Bank of New York >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/60909
|
| | |
| Title: | | What do drug monopolies cost consumers in developing countries?  |
| Authors: | | Hellerstein, Rebecca |
| Issue Date: | | 2011 |
| Series/Report no.: | | Staff Report, Federal Reserve Bank of New York 530 |
| Abstract: | | This paper quantifi es the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV. |
| Subjects: | | intellectual property rights international price discrimination TRIPS agreement pharmaceutical industry markups |
| JEL: | | D4 F13 L1 L65 O34 |
| Document Type: | | Working Paper |
| Appears in Collections: | | Staff Reports, Federal Reserve Bank of New York
|
| |
| | |
Download bibliographical data as:
BibTeX
|
| |
Share on:http://hdl.handle.net/10419/60909
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|